Evaluating Meaningful Changes in Patient‐Reported Outcome Measurement Information System–Fatigue Scores from Three Phase 3 Clinical Trials of Sarilumab for Patients With Rheumatoid Arthritis
Objective The aim of this study was to evaluate changes in fatigue measured by Patient‐Reported Outcome Measurement Information System (PROMIS)‐Fatigue scores in patients with rheumatoid arthritis (RA) who received sarilumab and to assess the proportion of patients achieving clinically meaningful ch...
Saved in:
Main Authors: | Clifton O. Bingham, Emily Molina, Amy Praestgaard, Stefano Fiore, David Cella |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11763 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders
by: Yoshifumi Tada, et al.
Published: (2023-01-01) -
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
by: Gerd R Burmester, et al.
Published: (2019-10-01) -
Assessment of correlation of fatigue in patients of rheumatoid arthritis using bristol rheumatoid arthritis fatigue multidimensional questionnaire score with disease activity – An Indian experience
by: Harpreet Singh, et al.
Published: (2023-01-01) -
Patient‐Reported Fatigue Associated with Joint Histopathology in Rheumatoid Arthritis
by: Diyu Pearce‐Fisher, et al.
Published: (2025-01-01) -
Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis
by: Cristina Gonzalez-Martin, et al.
Published: (2019-01-01)